Dbv Technologies S.A. (DBVT)Chief Medical Officer sold ~$1.3K
Pharis Mohideen, Chief Medical Officer at Dbv Technologies S.A., sold ~$1.3K of Dbv Technologies S.A. shares.
- ~$1.3K
- Approx. value · 464 sh @ $2.70
- 145K
- Holds after · shares reported
- Traded
- Jul 29, 2026
- Filed
- Jul 31, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 3, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
- Jun 3, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 3, 2026 the Board of Directors (the “ Board ”) of DBV Technologies S.A. (the “ Company ”), upon recommendation of the Compensation Committee (the “ Committee ”) of the Board, approved the DBV Technologies 2026 Performance Share Unit Plan (the “ Plan ”), and granted performance share units pursuant to the Plan (“ PSUs ”) to Daniel Tassé, the Company’s Chief Executive Officer (the “ CEO ,” or, alternately, the…”
- Jul 16, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 29, 2026 · this disclosureInsiderOfficer sold ~$1.3K of DBVT shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Dbv Technologies S.A.
For Dbv Technologies S.A., OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DBVT page.
Other recent filings by Pharis Mohideen, Chief Medical Officer
- SEC Form 4 at Dbv Technologies S.A. (DBVT)Feb 2, 2026
- SEC Form 4 at Dbv Technologies S.A. (DBVT)Nov 25, 2025
- SEC Form 4 at Dbv Technologies S.A. (DBVT)Nov 25, 2025
- SEC Form 4 at Dbv Technologies S.A. (DBVT)Jul 31, 2025
- SEC Form 4 at Dbv Technologies S.A. (DBVT)May 27, 2025
The full history of Pharis Mohideen, Chief Medical Officer is on the profile page.
How this filing works
Other disclosures at Dbv Technologies S.A.
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 29, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 4Feb 2, 2026
- SEC Form 4Dec 19, 2025
Everything OQRO holds on this company is on its DBVT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
